Rebuilding the immune system: promising new therapy uses the HIV virus itself to awaken the damaged immune system. Interview by Brian Coppedge and Dan Dawson.

: Dr. Ronald Moss, Senior Director of Medical and Scientific Affairs at the Immune Response Corporation, provides his opinions on immune restoration and a different approach to immune-based therapies. Dr. Moss explains why he thinks Remune is an effective immune-based therapy rather than a vaccine. Remune will allow the immune system to return to its normal functions as if it were healthy. The reasons that Remune does not evoke a strong antibody response and why it helps the body create more HIV-specific T-cells are explained. The major benefits and side effects of using Remune are detailed. How effectiveness of immune-based therapies can be measured, who would be appropriate for Remune therapy, and the status of Remune clinical trials are also discussed.